✦ LIBER ✦

Improvement in quality of diabetes control and concentrations of AGE-products in patients with type 1 and insulin-treated type 2 diabetes mellitus studied over a period of 10 years (JEVIN)

✍ Scribed by Ralf Schiel; Sybille Franke; Thilo Appel; Ulrich Voigt; Iain S. Ross; Rosemarie Kientsch-Engel; Günter Stein; Ulrich A. Müller

Book ID: 114343592
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 115 KB
Volume: 17
Category: Article
ISSN: 1056-8727
DOI: 10.1016/s1056-8727(02)00203-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Trends in the management of arterial hyp

Trends in the management of arterial hypertension in patients with type 1 and insulin-treated type 2 diabetes mellitus over a period of 10 years (1989/1990–1994/1995). Results of the JEVIN trial

✍ Ralf Schiel; Ulrich A. Müller; Wadim Beltschikow; Günter Stein 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 125 KB

Age, metabolic control and type of insul

Age, metabolic control and type of insulin regime influences health-related quality of life in children and adolescents with type 1 diabetes mellitus

✍ Verena M. Wagner; Esther Müller–Godeffroy; Simone von Sengbusch; Stefan Häger; U 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 246 KB

Progression of glycaemia and cardiovascu

Progression of glycaemia and cardiovascular risk factors in patients of different age groups with new type 2 diabetes over 5 years of follow-up in a diabetes quality improvement initiative

✍ Kirsten J. Coppell; Janet (EunHwa) Lee; Sheila M. Williams; Jim I. Mann 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 245 KB

Pravastatin compared to bezafibrate in t

Pravastatin compared to bezafibrate in the treatment of dyslipidemia in insulin-treated patients with Type 2 diabetes mellitus

✍ C. Rustemeijer; J. A. Schouten; H. J. Voerman; H. E. S. J. Hensgens; A. J. M. Do 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 99 KB 👁 2 views

Background Both HMG-CoA reductase inhibitors and ®bric acid derivates are used for the treatment of dyslipidemia in Type 2 diabetes patients. The aim of this study was to compare the lipid lowering effect of 40 mg pravastatin, a HMG-CoA reductase inhibitor, and 400 mg beza®brate, a ®bric acid deriva

Treating diabetes to accepted standards

Treating diabetes to accepted standards of care: A 10-year projection of the estimated economic and health impact in patients with type 1 and type 2 diabetes mellitus in the United States

✍ Michael E. Minshall; Stéphane Roze; Andrew J. Palmer; William J. Valentine; Volk 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 844 KB

Efficacy and Safety of a Mixture of Two

Efficacy and Safety of a Mixture of Two Different Brands of Insulin Products in Patients with Type 1 Diabetes Mellitus

✍ Jeng-Bin Chiou; Shih-Yi Lin; Chi-Yuan Jeng; Chin-Ho Yen; Wayne Huey-Herng Sheu 📂 Article 📅 2005 🏛 Elsevier Science 🌐 Chinese ⚖ 86 KB